Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Innovation and Technology Transfer Division, Kenya Medical Research Institute, Nairobi, Kenya.
F1000Res. 2024 May 9;12:1546. doi: 10.12688/f1000research.140226.3. eCollection 2023.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization recommended the use of alcohol-based hand rubs (ABHRs) to curb transmission, leading to increased production and use. This has posed a danger of production and use of poor-quality ABHRs.
This study assessed and compared the quality of ABHRs in the Kenyan market that were produced before and after the outbreak of the COVID-19 pandemic in March 2020. Quality testing was carried out against European EN 1500:2013 and Kenyan EAS 789:2013 Standards and 20 samples analyzed for alcohol content by GC-FID.
The study found that 27.8% of the peri-COVID-19 pandemic sanitizers had less than 90% bactericidal reduction activity as compared to 12.5% manufactured pre-COVID-19 pandemic. Only 25% peri-COVID-19 pandemic ABHRs met the EAS 789:2013 acceptable limit of over 60% alcohol content. Product adulteration with methanol was found in 20 % of the samples with only 5% complying with FDA approval limit of <0.063% v/v methanol. Study found no correlation between the total alcohol content and the efficacy of ABHRs.
The study found that more substandard products were produced during the pandemic. This raises a concern about possible emergence of alcohol resistant strains of microorganisms. The study therefore recommends an adequate quality monitoring system to curb against substandard products.
在 2019 年冠状病毒病(COVID-19)大流行之后,世界卫生组织建议使用酒精基手部消毒剂(ABHR)来遏制传播,导致其产量和使用增加。这带来了生产和使用劣质 ABHR 的危险。
本研究评估并比较了 COVID-19 大流行(2020 年 3 月)前后在肯尼亚市场上生产的 ABHR 的质量。根据欧洲 EN 1500:2013 和肯尼亚 EAS 789:2013 标准进行质量测试,并通过 GC-FID 对 20 个样本的酒精含量进行分析。
研究发现,与 COVID-19 大流行前相比,27.8%的 COVID-19 大流行期间生产的消毒剂杀菌减少活性低于 90%,而 COVID-19 大流行前生产的消毒剂为 12.5%。只有 25%的 COVID-19 大流行期间的 ABHR 符合 EAS 789:2013 可接受的酒精含量超过 60%的限制。研究发现,20%的样本中存在甲醇产品掺假,只有 5%符合 FDA 批准的<0.063%v/v 甲醇限量。研究发现,ABHR 的总酒精含量与功效之间没有相关性。
研究发现,大流行期间生产了更多的不合格产品。这引发了人们对可能出现耐酒精微生物菌株的担忧。因此,研究建议建立一个充分的质量监测系统来遏制不合格产品。